Gerassimos E. Voutsinas

Statistics

Publications

Citations

1.1K

H-Index

Active since

1994

Affiliations

National Centre of Scientific Research "Demokritos"(Current)

National and Kapodistrian University of Athens

Institute of Biosciences & Applications

Harvard University

Dana-Farber Cancer Institute

Gerassimos E. Voutsinas is an author at National Centre of Scientific Research "Demokritos" specializing in oncology, molecular oncology, and medicine.

Publications per year

1994–2022

Publications

c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations

Penelope Korkolopoulou, Athina Goudopoulou, Gerassimos E. Voutsinas et al. · Urology · 2004 · 70 citations

Medicine, Oncology, Urology +14

Epidermal Growth Factor Receptor as a Therapeutic Target in Human Thyroid Carcinoma: Mutational and Functional Analysis

Constantine S. Mitsiades, Vassiliki Kotoula, Vassiliki Poulaki et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 62 citations · Full text

Medicine, Oncology, Pharmacology +17

Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease

Gerassimos E. Voutsinas, Eleana F. Stavrou, Gerassimos Karousos et al. · Human Mutation · 2010 · 61 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Targeting <i>BRAF</i>V600E in thyroid carcinoma: therapeutic implications

Constantine S. Mitsiades, Joseph Negri, Ciaran J. McMullan et al. · Molecular Cancer Therapeutics · 2007 · 57 citations · Full text

Medicine, Genetics, Oncology +17

17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells

Panagiotis K. Karkoulis, Dimitrios J. Stravopodis, Lukas H. Margaritis et al. · BMC Cancer · 2010 · 56 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 32